Search filters

List of works by Pippa G Corrie

A prospective observational safety study of patients with BRAFV 600 -mutated unresectable or metastatic melanoma treated with vemurafenib (Zelboraf Safety Study)

scientific article published on 10 February 2019

Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial

scientific article published on 21 June 2018

Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position

scientific article published on 08 July 2020

Enhanced detection of circulating tumor DNA by fragment size analysis

scientific article published on 01 November 2018

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

scientific article published on 19 June 2014

Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic"

scientific article published on 03 November 2020

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

scientific article published on 01 April 2020

Tebentafusp, a TCR/anti-CD3 bispecific fusion protein targeting gp100, potently activated anti-tumor immune responses in patients with metastatic melanoma

scientific article published on 18 August 2020

The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence

scientific article published on 07 October 2020

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.

scientific article

ctDNA monitoring using patient-specific sequencing and integration of variant reads

scientific article published on 01 June 2020

sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients

scientific article published on 23 October 2020

Paulina is supported by:

About Paulina

Help